Aurinia Pharmaceuticals Inc (AUP.TO)
AUP.TO on Toronto Stock Exchange
8.42CAD
22 Apr 2019
8.42CAD
22 Apr 2019
Change (% chg)
$-0.03 (-0.36%)
$-0.03 (-0.36%)
Prev Close
$8.45
$8.45
Open
$8.36
$8.36
Day's High
$8.48
$8.48
Day's Low
$8.35
$8.35
Volume
6,079
6,079
Avg. Vol
77,008
77,008
52-wk High
$10.47
$10.47
52-wk Low
$6.58
$6.58
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec '18 | 0.03 | -0.171 |
| Sep '18 | 0.38 | -0.215 | |
| Jun '18 | 0.03 | -0.186 | |
| Mar '18 | 0.03 | -0.184 | |
| FY 2017 | Dec '17 | 0.03 | -0.040 |
| Sep '17 | 0.03 | -0.157 | |
| Jun '17 | 0.33 | -0.029 | |
| Mar '17 | 0.03 | -0.916 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Quarter Ending Sep-19 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Year Ending Dec-19 | 2 | 0.21 | 0.30 | 0.12 | 0.15 |
| Year Ending Dec-20 | 2 | 19.66 | 39.12 | 0.20 | 39.06 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 2 | -0.16 | -0.11 | -0.20 | -- |
| Quarter Ending Sep-19 | 2 | -0.17 | -0.10 | -0.23 | -- |
| Year Ending Dec-19 | 3 | -0.67 | -0.42 | -0.87 | -0.65 |
| Year Ending Dec-20 | 3 | -0.28 | 0.06 | -0.57 | -0.12 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 109.48 | 62.40 | |
| P/E High - Last 5 Yrs. | -- | 163.07 | 56.31 | |
| P/E Low - Last 5 Yrs. | -- | 52.30 | 28.72 | |
| Beta | 1.57 | 1.16 | 0.93 | |
| Price to Sales (TTM) | 1,250.52 | 46.04 | 9.62 | |
| Price to Book (MRQ) | 4.81 | 13.22 | 4.53 | |
| Price to Tangible Book (MRQ) | 5.79 | 18.84 | 7.71 | |
| Price to Cash Flow (TTM) | -- | 73.00 | 43.23 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.09 | 1.54 | |
| Dividend Yield - 5 Year Avg | -- | 0.05 | 0.70 | |
| Dividend 5 Year Growth Rate | -- | 0.72 | 2.97 | |
| Payout Ratio(TTM) | -- | 8.42 | 21.72 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -6.45 | 23.35 | 9.20 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 10.24 | 67.54 | 8.35 | |
| Sales - 5 Yr. Growth Rate | -13.73 | 33.23 | 11.12 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -331.46 | -90.23 | 110.61 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 33.77 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 21.68 | 6.92 | |
| Capital Spending - 5 Yr. Growth Rate | -7.03 | 25.56 | 7.61 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.71 | 2.66 |
| Current Ratio (MRQ) | 18.30 | 3.55 | 3.63 |
| LT Debt to Equity (MRQ) | 0.00 | 7.07 | 13.26 |
| Total Debt to Equity (MRQ) | 0.00 | 20.06 | 16.97 |
| Interest Coverage (TTM) | -2.03 | 10.02 | 27.27 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 25.18 | 50.31 | |
| Gross Margin - 5 Yr. Avg. | -- | 59.97 | 50.77 | |
| EBITD Margin (TTM) | -11,791.14 | -- | -- | |
| EBITD - 5 Yr. Avg | -10,170.24 | -10.84 | 15.78 | |
| Operating Margin (TTM) | -12,129.16 | -109.08 | -2.09 | |
| Operating Margin - 5 Yr. Avg. | -10,705.23 | -26.44 | 11.11 | |
| Pre-Tax Margin (TTM) | -13,833.04 | -109.66 | -2.92 | |
| Pre-Tax Margin - 5 Yr. Avg. | -12,502.36 | -29.17 | 16.76 | |
| Net Profit Margin (TTM) | -13,848.81 | -116.04 | -6.86 | |
| Net Profit Margin - 5 Yr. Avg. | -12,507.01 | -34.35 | 11.72 | |
| Effective Tax Rate (TTM) | -- | 19.91 | 22.86 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 19.61 | 23.86 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 15,896 | 8,511,584 | 773,166,387 | |
| Net Income/Employee (TTM) | -2,201,453 | 1,995,061 | 89,056,262 | |
| Receivable Turnover (TTM) | 2.84 | 2.36 | 5.22 | |
| Inventory Turnover (TTM) | -- | 2.31 | 3.65 | |
| Asset Turnover (TTM) | 0.00 | 0.32 | 0.81 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -38.20 | 6.35 | 9.54 | |
| Return on Assets - 5 Yr. Avg. | -47.02 | 6.24 | 10.49 | |
| Return on Investment (TTM) | -40.04 | 7.96 | 11.78 | |
| Return on Investment - 5 Yr. Avg. | -50.56 | 8.16 | 13.39 | |
| Return on Equity (TTM) | -46.08 | 8.11 | 12.61 | |
| Return on Equity - 5 Yr. Avg. | -61.62 | 9.28 | 14.86 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 10.24 | 25.36 | -13.73 |
| EPS (TTM) % | 17.83 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aurinia Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -6.22 | -8.29 | 83 | 90 |
| 13 Week | -15.16 | -22.32 | 46 | 74 |
| 26 Week | 13.88 | 5.60 | 99 | 4 |
| 52 Week | 18.35 | 10.63 | 99 | 26 |
| YTD | -8.94 | -21.50 | 48 | 23 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 24.59% |
| # of Holders: | 77 |
| Total Shares Held: | 22,477,290 |
| 3 Mo. Net Change: | -64,724 |
| # New Positions: | 1 |
| # Closed Positions: | 2 |
| # Increased Positions: | 1 |
| # Reduced Positions: | 5 |
| # Net Buyers: | -4 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.